| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |